Docetaxel with androgen deprivation therapy (ADT) and radiotherapy (RT) for highrisk localized prostate cancer (HRLPC): An ICECaP individual patient-data (IPD) meta-analysis of randomized controlled trials (RCTs)

Category Systematic review
JournalJ. Clin. Oncol.
Year 2025
This article has no abstract
Epistemonikos ID: 85ffbd479f88306b0ccfeab71bd56b6043e47346
First added on: Sep 04, 2025